About this product
A topical cream designed to shorten the duration and reduce severity of cold sores caused by the herpes simplex virus.
Best for
The Guru Index verdict
Mixed
~Mixed · 59%What the gurus are saying
Gurus are skeptical about Abreva's real-world payoff. The main complaint is that it demands five daily applications to deliver only marginal results, typically shortening cold sore duration by roughly one day. The scientific evidence itself is mixed, with some studies supporting efficacy and others showing no benefit. At around $37 for two treatments, reviewers question whether the modest benefit justifies the cost and inconvenience, especially for people prone to recurrent outbreaks.
Key actives & flags
Full ingredients
Where to buy
Every take we've logged from this product's reviews across YouTube. Click any row to watch the moment they said it.
Other products the same gurus have weighed in on, plus more from this brand and category.
Stories where our editors dug into this product or its brand.
A weekly read of the takes worth catching up on: the raves, the splits, the ones the gurus won't shut up about. Free, no spam, unsubscribe whenever.
Subscribe to the digestWe use cookies to understand how the site is used. Analytics cookies are only set if you accept. See our Cookie Policy.